Literature DB >> 22564039

Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease.

Kosuke Ito1, Tomotaka Kawayama, Yoshihisa Shoji, Noriko Fukushima, Kazuko Matsunaga, Nobutaka Edakuni, Naohisa Uchimura, Tomoaki Hoshino.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients with chronic obstructive pulmonary disease (COPD) may experience depression and sleep disorders, which can adversely affect their health-related quality of life (HRQOL). The aim of this study was to investigate depression and sleep disorders among 85 COPD patients and 46 control subjects, aged 40 years and over.
METHODS: Patients underwent spirometry and arterial blood gas analysis, self-completed St. George's respiratory questionnaire and were assessed on the center for epidemiologic studies depression (CES-D) and the Pittsburgh sleep quality index (PSQI). The frequency of exacerbations among COPD patients was prospectively monitored for 12 months.
RESULTS: The prevalence of depression and sleep disorders was significantly higher among COPD patients than control subjects. The relative risks (95% confidence interval) of depression and sleep disorders were 7.58 (1.03 to 55.8) and 1.82 (1.03 to 3.22), respectively, in COPD patients compared with control subjects. Among COPD patients, there was a correlation between CES-D and PSQI. Lower body mass index, more severe dyspnoea, poorer HRQOL, lower partial pressure of arterial oxygen and higher partial pressure of arterial carbon dioxide were significantly associated with the incidence of depression and sleep disorders. Exacerbations and hospitalizations were more frequent among COPD patients with depression than those with sleep disorders alone or those without depression or sleep disorders.
CONCLUSIONS: Depression and sleep disorders are very common co-morbidities among COPD patients and significantly reduce activities and HRQOL among these patients. Depression, but not sleep disorder, is an independent risk factor for exacerbations and hospitalization among COPD patients.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564039     DOI: 10.1111/j.1440-1843.2012.02190.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  4 in total

1.  Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease.

Authors:  Tomomi Sekiduka-Kumano; Tomotaka Kawayama; Kosuke Ito; Yoshihisa Shoji; Kazuko Matsunaga; Masaki Okamoto; Nobutaka Edakuni; Haruki Imaoka; Naohisa Uchimura; Tomoaki Hoshino
Journal:  BMC Psychiatry       Date:  2013-05-31       Impact factor: 3.630

2.  Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study.

Authors:  Young Seok Lee; Sunghoon Park; Yeon-Mok Oh; Sang-Do Lee; Sung-Woo Park; Young Sam Kim; Kwang Ho In; Bock Hyun Jung; Kwan Ho Lee; Seung Won Ra; Yong Il Hwang; Yong-Bum Park; Ki-Suck Jung
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

Review 3.  Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary disease.

Authors:  Adam P Garrow; Janelle Yorke; Naimat Khan; Jørgen Vestbo; Dave Singh; Sarah Tyson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-09

4.  "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.

Authors:  Ryusuke Tomioka; Tomotaka Kawayama; Masashi Suetomo; Takashi Kinoshita; Yoshihisa Tokunaga; Haruki Imaoka; Kazuko Matsunaga; Masaki Okamoto; Tomoaki Hoshino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.